Need a specific person's email?
Browse Sio Gene Therapies's employee directory (about 67 employees) and reveal verified emails free.
Sio Gene Therapies's most common email format is First.Last@axovant.com (ex. John.Doe@axovant.com), used for 98% of axovant.com addresses. Sio Gene Therapies uses 3 email patterns across 2 domains: axovant.com and siogtx.com. Percentages are the share of addresses within each domain.
| Format | Example | Share of axovant.com |
|---|---|---|
| First.Last@axovant.comMost common | John.Doe@axovant.com | |
| FirstMiddle.Last@axovant.com | JohnMichael.Doe@axovant.com |
| Format | Example | Share of siogtx.com |
|---|---|---|
| First.Last@siogtx.comMost common | John.Doe@siogtx.com |
Browse Sio Gene Therapies's employee directory (about 67 employees) and reveal verified emails free.
BiotechnologyNew York, United States51-200 Employees
Sio Gene Therapies is a biotechnology company focused on developing genetic medicines through gene therapy, aiming to radically improve patient outcomes. Its clinical pipeline centers on gene therapies intended for GM1 gangliosidosis and Tay-Sachs/Sandhoff diseases, rare pediatric conditions caused by single-gene defects, with potential for curative benefit. The company is also pursuing applications for more prevalent disorders such as Parkinson's disease to broaden the reach of gene therapy. Headquartered in New York City, New York, the company operates as a mid-sized biotechnology firm supported by collaborations with academic, industry, and patient advocacy groups. Its activities place it in the clinical-stage segment of biotechnology, and it has engaged in partnerships and program updates over time, including a 2020 collaboration with Invitae to offer genetic testing for pediatric lysosomal storage diseases.
Most common format
First.Last@axovant.com
Example: John.Doe@axovant.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.